Showing results (1-10 of 354) with videos related to
Sort By:
Pageof 36
Hematology/Oncology Clinics of North America|January 17, 2012
Genetic risk and gynecologic cancersLaura L Holman, Karen H LuGynecologic Oncology|March 4, 2014
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriersLaura L Holman, Sue Friedman, Molly S Daniels, et al.American Journal of Obstetrics and Gynecology|November 20, 2013
Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screeningLaura L Holman, Karen H Lu, Robert C Bast, et al.Gynecologic Oncology|May 9, 2018
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutationsDenise R Nebgen, Jean Hurteau, Laura L Holman, et al.Current Opinion in Obstetrics & Gynecology|January 15, 2011
Update on sentinel lymph node evaluation in gynecologic malignanciesKatina Robison, Laura L Holman, Richard G MooreClinical Therapeutics|March 14, 2018
An Overview of Immune Checkpoint Inhibitors in Gynecologic CancersTara Castellano, Kathleen N Moore, Laura L HolmanJournal of Minimally Invasive Gynecology|January 11, 2014
Sentinel lymph node evaluation in women with cervical cancerLaura L Holman, Charles F Levenback, Michael FrumovitzBMC Cancer|October 18, 2015
Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case reportLaura L Holman, Yulan Ren, Shannon N WestinFamilial Cancer|July 20, 2007
Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxisKaren H LuPageof 36